ADMA Biologics (ADMA)
(Delayed Data from NSDQ)
$9.56 USD
+0.09 (0.95%)
Updated May 24, 2024 04:00 PM ET
After-Market: $9.56 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth B Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ADMA 9.56 +0.09(0.95%)
Will ADMA be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for ADMA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ADMA
Zacks.com featured highlights ADMA Biologics, Northern Technologies, PlayAGS, Merchants Bank and Strategic Education
5 Stocks With Recent Price Strength to Tap May's Rally
ADMA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year?
Adma Biologics (ADMA) Surpasses Q1 Earnings and Revenue Estimates
Adma Biologics (ADMA) Rises Higher Than Market: Key Facts
Other News for ADMA
July 19th Options Now Available For ADMA Biologics
Biotech Alert: Searches spiking for these stocks today
Giving ADMA Biologics A Well-Deserved 'Booyah'
Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
ADMA Biologics Inc (ADMA) Surpasses Analyst Revenue and Earnings Forecasts in Q1 2024